Publications | Lund University Publications

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Hutchings%2C+Martin%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Hutchings%2C+Martin%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2021
Mark Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
Lokhande, Lavanya ^LU ; Kuci Emruli, Venera ^LU ; Eskelund, Christian Winther ; Kolstad, Arne ; Hutchings, Martin ; Räty, Riikka ; Niemann, Carsten Utoft ; Grønbæk, Kirsten ; Jerkeman, Mats ^LU and Ek, Sara ^LU (2021) In Cancer Reports
- Contribution to journal › Article
Mark Detailed Long-Term Follow-Up of Patients Who Relapsed after the Nordic Mantle Cell Lymphoma Trials : MCL2 and MCL3
Eskelund, Christian Winther ; Dimopoulos, Kostas ; Kolstad, Arne ; Glimelius, Ingrid ; Räty, Riikka ; Gjerdrum, Lise Mette Rahbek ; Sonnevi, Kristina ; Josefsson, Pär ; Nilsson-Ehle, Herman and Bentzen, Hans H.N. , et al. (2021) In HemaSphere
- Contribution to journal › Article
2020
Mark Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
Lokhande, Lavanya ^LU ; Kuci Emruli, Venera ^LU ; Kolstad, Arne ; Hutchings, Martin ; Räty, Riikka ; Jerkeman, Mats ^LU and Ek, Sara ^LU (2020) In BMC Cancer 20(1).
- Contribution to journal › Article
2018
Mark Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON) : A multicentre, open-label, single-arm, phase 2 trial
Jerkeman, Mats ^LU ; Eskelund, Christian Winther ; Hutchings, Martin ; Räty, Riikka ; Wader, Karin Fahl ; Laurell, Anna ^LU ; Toldbod, Helle ; Pedersen, Lone Bredo ; Niemann, Carsten Utoft and Dahl, Christina , et al. (2018) In The Lancet Haematology 5(3). p.109-116
- Contribution to journal › Article
2016
Mark No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
Jakobsen, Lasse H ; Hutchings, Martin ; de Nully Brown, Peter ; Linderoth, Johan ^LU ; Mylam, Karen J ; Molin, Daniel ; Johnsen, Hans E ; Bøgsted, Martin ; Jerkeman, Mats ^LU and El-Galaly, Tarec C (2016) In British Journal of Haematology
- Contribution to journal › Article
2015
Mark Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.
El-Galaly, Tarec Christoffer ; Jakobsen, Lasse Hjort ; Hutchings, Martin ; de Nully Brown, Peter ; Nilsson-Ehle, Herman ; Szekely, Erzsébet ^LU ; Mylam, Karen Juul ; Hjalmar, Viktoria ; Johnsen, Hans Erik and Bøgsted, Martin , et al. (2015) In Journal of Clinical Oncology 33(34). p.3993-3998
- Contribution to journal › Article
Mark F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
Mylam, Karen Juul ; Kostakoglu, Lale ; Hutchings, Martin ; Coleman, Morton ; Lamonica, Dominick ; Czuczman, Myron S. ; Diehl, Louis F. ; Nielsen, Anne L. ; Jensen, Paw and Loft, Annika , et al. (2015) In Leukemia & Lymphoma 56(7). p.2005-2012
- Contribution to journal › Article

your query:: Remove author: Hutchings, Martin